Vemurafenib for high risk melanoma patients
Dr Karl Lewis - University of Colorado Denver, Colorado, USA
11 Sep 2017
Dabrafenib plus trametinib for stage III mutant melanoma
Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
11 Sep 2017
Nivolumab vs ipilimumab for high risk melanoma patients
Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA
11 Sep 2017
Checkmate 238: Adjuvant checkpoint therapy after melanoma resection
Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA
11 Sep 2017
The METRIC trial of trametinib, five years on
Prof Dirk Schadendorf - Essen University Hospital, Essen, Germany
10 Sep 2017
New strategies in melanoma care
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
10 Sep 2017
Reduced work ability in cancer survivors
Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway
9 Sep 2017
Problems with survivorship care in Europe
Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy
9 Sep 2017
Underprovision and inequality of specialised cancer care
Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Gree...
9 Sep 2017
Editor's Choice for August 2017
Prof Gordon McVie - Founding Editor, ecancer
23 Aug 2017
Editor's Choice for July 17
Prof Gordon McVie - Founding Editor, ecancer
28 Jul 2017
iManageCancer: Serious Games for Kids
Stefan Hoffman - Serious Games Solutions, Potsdam, Germany
28 Jul 2017
